Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Aug 9;64(3):453–464. doi: 10.1007/s00234-021-02778-9

MR vessel wall imaging in cerebral bacterial and fungal infections

Neha Choudhary 1, Sameer Vyas 1,, Chirag Kamal Ahuja 1, Manish Modi 2, Naveen Sankhyan 3, Renu Suthar 3, Jitendra Kumar Sahu 3, Manoj K Goyal 2, Anuj Prabhakar 1, Paramjeet Singh 1
PMCID: PMC8349608  PMID: 34368896

Abstract

Purpose

Central nervous system (CNS) bacterial and fungal infections can cause secondary vasculitis which worsens the prognosis due to development of complications like infarctions or hemorrhages. In this prospective study, we aim to study intracranial vessel wall imaging findings in bacterial and fungal infections.

Methods

We included 12 cases of nontubercular bacterial and fungal CNS infections each, in whom definitive microbiological diagnosis could be made. High-resolution vessel wall imaging (VWI) and time of flight MR angiography (TOF MRA) were incorporated in the routine imaging protocol. All cases were evaluated for the presence of vascular enhancement, pattern of enhancement, and stenosis on VWI. Statistical analysis was done to evaluate association between findings of vessel wall imaging and infarctions.

Results

We found infarctions in 5 out of 12 cases (41.7%) of the bacterial group and 7 out of 12 cases (58.3%) of the fungal group. Vessel wall enhancement was seen in 5 cases (41.7%) of the bacterial group and 9 cases (75%) of the fungal group. There was a significant association between infarctions and vessel wall enhancement in the fungal group. However, pattern of enhancement or stenosis on VWI was not significantly associated with presence of infarction. VWI detected more cases of vascular involvement than TOF MRA.

Conclusion

Secondary infectious vasculitis in bacterial and fungal infections can be detected by VWI, which can play an important role in better patient management as detection of vascular involvement can prompt early treatment to prevent complications like infarctions or hemorrhages.

Keywords: Bacterial infection, Fungal infections, CNS vasculopathy, Vessel wall imaging

Introduction

Secondary vasculitis is a serious complication of CNS infections and is known to occur in tubercular, bacterial, viral, fungal, and parasitic infections etc. [1]. The morbid complications of infective vasculitis encompass ischemic or hemorrhagic stroke, venous thrombosis, and aneurysm formation [2]. Imaging evaluations should be directed to detect these complications in early stage for better disease prognostication. Mechanisms of vascular involvement include infiltration of vessels by basal exudates, extension of inflammation via meninges, hematogenous spread via vasa vasorum, immune-mediated, toxic effects of released endotoxin or exotoxin by inciting organisms, or infection-induced procoagulant state [1, 3, 4]. Inflammation of the vessel wall leads to circumferential mural thickening, stenosis, beading, or thrombosis. Necrotizing inflammation causing vascular destruction may cause aneurysm formation and hemorrhage. Inflammation of the venous walls may lead to venous thrombosis. In earlier times, the diagnosis of vasculitis was done by cortical and meningeal biopsies. However, with the advent of vessel wall imaging, diagnosis of these vascular complications has become easier.

CT angiography, MR angiography, and DSA can show luminal abnormality in the form of stenosis, dilatation, or irregularity with no information about the abnormalities of the vessel wall. There are many pathologies like intracranial atherosclerosis (ICAD) or vasculitis which may not cause any apparent change in lumen diameter but can cause changes in the vessel wall which may be missed in routine imaging [5]. Vessel wall imaging can directly image the vessel wall using high-resolution spin echo MR imaging technique. Luminal blood and surrounding CSF are suppressed by various techniques which enable visualization of intervening vessel wall and its morphology [6].

The cerebrovascular complications may produce focal neurological deficits, seizures, or altered sensorium. However, many times clinical diagnosis is difficult as symptoms are masked by the presence of other manifestations of CNS infections, like altered sensorium. In these cases, VWI plays an important role for the identification of vascular involvement. On the detection of vascular involvement, appropriate early management in the form of antiplatelets and anti-inflammatory drugs can be initiated to prevent complications. Enhancement on VWI is an indicator of activity of the disease, thus plays a role in deciding the duration of treatment [7]. VWI is also helpful in guiding sites of involvement for biopsies [7].

Common organisms responsible for infective vasculitis in bacterial infections are Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, Neisseria meningitidis, Mycoplasma pneumoniae, and Haemophilus influenzae. Vascular complications are also seen in fungal infections, especially in cases of angioinvasive hyphae forming larger fungi, e.g., Aspergillus and Mucor. Small fungi like Candida and Cryptococcus may also cause vascular involvement, through involvement of microcirculation. These vascular complications are common in advanced stage of disease and in immunocompromised individuals.

The role of VWI in the detection and characterization of vascular involvement in tubercular meningitis has been described [5, 7, 8]. However, vessel wall imaging findings in non-tubercular bacterial and fungal CNS vasculitis have not been described in literature yet. In this study, we attempt to characterize vascular complications of bacterial and fungal infections using vessel wall imaging. This will allow us to understand the pathophysiology of vascular involvement in these CNS infections which can contribute to modify management in order to avoid vascular complications like infarction or hemorrhage.

Materials and methods

We included vessel wall imaging in routine imaging protocol of consecutive cases of suspected bacterial and fungal CNS infections referred for MRI evaluation. The cases were followed up for definitive diagnosis of infective pathology. Only those cases in which definitive diagnosis could be made by CSF gram staining/CSF culture/biopsy/PCR were included in the study. We had a total of 12 cases of proven bacterial infection. Three were known cases of staphylococcal sepsis. Gram staining of CSF was positive for cocci in 2 patients. CSF culture in 4 patients revealed streptococci, staphylococci, and Haemophilus influenzae. Surgery was performed in 2 patients (one case of right temporal abscess and the other case of left CP angle abscess) and microbiological examination of post op specimen was positive for Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. One case of scrub typhus had positive CSF PCR for Orientia tsutsugamushi.

We had a total of 12 cases of proven fungal infections. Seven cases had proven fungal sinusitis (Aspergillus and Mucor infections) and had cerebral extension. Two cases had cerebral fungal abscesses which were aspirated. One case of Candida infection was biopsy proven. Two cases of Cryptococcus infection had positive India ink and Cryptococcus antigen in CSF examination.

Vessel wall imaging MRI acquisition

All cases underwent MR scanning either in 1.5 T Siemens Magnetom Aera System, Erlangen, Germany or 3 T GE Discovery MR 750w, Norwalk, Connecticut, USA or 3 T Philips Ingenia Koninklijke MRI System, Best, Netherlands. For vessel wall imaging, high-resolution pre- and post-contrast 3D T1 FS sequences (SPACE, CUBE, and VISTA in Siemens, GE, and Philips respectively) were acquired. MRI protocols on a 1.5-T Siemens scanner were as follows: TR = 600 ms, TE = 7.2 ms, flip angle = 90, FOV = 250, slice thickness = 1, matrix = 256, and number of slices = 192. The protocols on a 3-T GE scanner were as follows: TR = 650 ms, TE = 13 ms, flip angle = 90, FOV = 220, slice thickness = 0.7, matrix = 256, and number of slices = 176. Protocols on a 3-T Philips scanner were as follows: TR = 400 ms, TE = 19 ms, flip angle = 90, FOV = 202, slice thickness = 1, matrix = 240, and number of slices = 200. Other routine sequences and 3D TOF MRA were also acquired.

Image analysis

Supraclinoid ICA, A1 and A2 segments of ACA, M1 and M2 segments of MCA, P1 and P2 segments of PCA, and basilar artery were evaluated on VWI for the presence of enhancement. Categorization of enhancement pattern into smooth and nodular was done. If part of circumference of the vessel wall was showing enhancement or if part of enhancing wall was twice as thick as the rest of the wall, then it was termed as nodular enhancement. Stenosis of the arteries was measured and classified into grade I (< 50% stenosis), grade II (50–70% stenosis), and grade III (> 70% stenosis).

Results

Bacterial CNS infections (Table 1)

Table 1.

Details of cases of bacterial infections

Sr. no Age (in years) Sex Imaging findings Infarcts TOF MRA VWI-sites of enhancement Grade of stenosis on VWI Pattern of enhancement on VWI Organism
1 0.5 M Left Sylvian fissure abscess, meningitis (Fig. 1) Left MCA territory acute infarct Nonvisualization of left ICA and left MCA Left ICA, left MCA 3 Nodular Streptococcus pneumoniae, Haemophilus influenzae
2 11 M Ventriculitis, meningitis Focal acute infarct in left MCA territory Normal No enhancement - - Staphylococcus
3 20 M Hydrocephalus, meningitis No infarct Normal No enhancement - - Cocci in gram staining of CSF
4 57 M Post-traumatic CSF rhinorrhea, meningitis, encephalomalacia in bilateral frontal and left occipital lobe No infarct Normal No enhancement - - Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes
5 27 F Right temporal abscess No infarct Normal No enhancement - - Staphylococcus, Streptococcus pyogenes, Streptococcus pneumoniae
6 10 F Meningitis, subdural empyema along the clivus (Fig. 2) No infarct Normal BA No stenosis Smooth Staphylococcus
7 60 M Ventriculitis Acute infarcts in right ACA, left PCA, right MCA, left ACA-MCA and B/L MCA-PCA watershed territory Stenosis of right A2 ACA B/L ICA, right M1 MCA, B/L A2 ACA, B/L P1 PCA 1 Smooth Streptococcus b
8 73 M Ventriculitis Acute left MCA territory and B/L ACA-MCA watershed territory infarcts Normal Right ICA, B/L MCA No stenosis Smooth Cocci in gram staining of CSF
9 35 F Left CP angle abscess No infarct Normal No enhancement - - Staphylococcus, Streptococcus pyogenes
10 15 M Meningitis Multiple hemorrhagic acute infarcts in left MCA, B/L ACA-MCA watershed territory, and B/L PCA territories Normal No enhancement - - Staphylococcus
11 14 F Meningitis, ventriculitis, diffuse cerebral edema No infarct Stenosis of B/L ICA, B/L MCA, B/L PCA, BA B/L ICA, B/L MCA, B/L PCA, BA 2 Smooth Staphylococcus, Streptococcus pneumoniae
12 20 F Scrub typhus-thalamic altered signal intensity No infarct Normal No enhancement - - O. tsutsugamushi

We found infarctions in 5 of 12 cases (41.7%) of bacterial infections. Three cases had single territory infarcts while 2 cases had multi-territory infarcts. Maximum number of infarcts were seen in MCA territory (n = 5, 41.7%) and watershed territories (n = 3, 25%), followed by PCA (n = 2, 16.7%) and ACA territories (n = 1, 8.3%). Vessel wall enhancement was seen in 5 cases, 3 of which had infarcts in the territory of involved vessel. Three out of 5 cases of infarcts showed enhancement in the responsible artery, while 2 cases of infarcts did not show any vascular involvement. Most common sites of vessel wall enhancement were ICA (n = 4; bilateral in 2 cases and unilateral in 2 cases) and MCA (n = 4, bilateral in 2 cases and unilateral in 2 cases) followed by ACA (n = 2), PCA (n = 2), and BA (n = 2). No significant association was found between infarctions and vessel wall enhancement (p = 0.1) (Table 3). Three cases showing vessel wall enhancement had shown stenosis of the artery. Enhancement pattern was smooth in 4 cases and nodular in 1 case. No significant association between infarction and pattern of enhancement or stenosis on VWI was found (p > 0.05). TOF MRA showed abnormality in 3 cases in the form of stenosis but failed to detect vascular involvement in 2 cases which showed enhancement on VWI without significant stenosis.

Table 3.

Association between enhancement on VWI and infarctions

Infarct +  Infarct −  p value
Bacterial infections VWI +  3 2 0.5
VWI −  2 5
Fungal infections VWI +  7 2 0.04
VWI −  0 3

Fungal CNS infections (Table 2)

Table 2.

Details of cases of fungal infections

Sr. no Age (in years) Sex Imaging findings Infarcts TOF MRA VWI-sites of enhancement Grade of stenosis on VWI Pattern of enhancement on VWI Organism
1 35 F Altered signal intensity lesions in basal ganglia No infarcts Normal No enhancement - - Cryptococcus
2 10 M Leptomeningitis with hemorrhages in left Sylvian fissure Left MCA territory subacute infarct Stenosis of left ICA and MCA Left ICA, left M1 and M2 MCA, left A1 ACA, left P1 and P2 PCA Grade 1 in left ICA and MCA Smooth Candida
3 21 F Fungal sinusitis, enhancing masses in bilateral cavernous sinuses and along bilateral tentorium, meningitis Acute infarcts in right ACA, left AICA, and left PICA Severe stenosis of BA, right ACA B/L ICA, right ACA, B/L MCA, BA 3 (BA and right ACA) Nodular Aspergillus
4 51 M Right temporal fungal abscess, meningitis No infarct Normal Right ICA No stenosis Smooth Aspergillus
5 60 M Peripherally enhancing bifrontal fungal masses with hemorrhages in left frontal lobe, meningitis No infarct Normal No enhancement - - Aspergillus
6 68 M Fungal sinusitis, meningitis, IVH, hydrocephalus (Fig. 3) B/L ACA, B/L ACA-MCA watershed hemorrhagic acute infarcts Right A2 ACA severe stenosis, mild stenosis of left A2 ACA, mycotic aneurysm of right A2 ACA B/L ACA, mycotic aneurysm of right A2 ACA Grade 3 in right A2 ACA Nodular Aspergillus
7 17 M Leptomeningitis No infarct Normal No enhancement - - Cryptococcus
8 42 M Skull base osteomyelitis, pachymeningitis, B/L cavernous sinus involvement (Fig. 4) Acute infarcts in left hemipons, left cerebellum, right ACA-MCA watershed territory Normal BA No stenosis in 1st scan, occlusion of BA in follow-up scan Nodular Mucor
9 35 M Rhino-orbito-cerebral mucormycosis, left frontal abscess, pachymeningitis, left cavernous sinus involvement Left ACA-MCA watershed acute infarcts Stenosis of left cavernous and supraclinoid ICA Left supraclinoid ICA 2 Smooth Mucor
10 27 M Basal exudates, sphenoid sinusitis, clival involvement Chronic infarct in left MCA territory Stenosis of left MCA Left M1 MCA and BA 2 (left M1 MCA) Smooth Aspergillus
11 54 F Right frontal abscess, pachymeningitis, right cavernous sinus involvement, right trigeminal nerve enhancement No infarct Right ICA occlusion Supraclinoid right ICA Occlusion of cavernous ICA and grade 2 stenosis of supraclinoid ICA Nodular Mucor
12 35 M Homogenously enhancing fungal mass in prepontine cistern with clival involvement, meningitis Chronic infarct in right hemipons and right cerebellum Basilar occlusion BA, left V4 VA Grade 3 in BA Smooth Aspergillus

Infarcts were seen in 7 out of 12 cases of fungal infections (58.3%) while 9 cases (75%) showed vessel wall enhancement. Causative fungi were Aspergillus in 6 cases, Mucor in 3 cases, Cryptococcus in 2 cases, and Candida in 1 case. Six had acute infarcts and 1 had chronic infarct. Multi-territorial infarcts were seen in 4 cases (33.3%) and single territory infarcts was seen in 3 cases (25%). Common locations of infarction were ACA territory (n = 2), MCA territory (n = 2), BA territory in the brainstem (n = 2), and watershed territories (n = 3). Seven of the 9 cases which showed vessel wall enhancement had infarction in the territory of involved vessel. Two cases showed vascular enhancement but no infarcts. All 7 cases with infarct showed enhancement of the responsible artery. Significant correlation was found between infarctions and vessel wall enhancement (p = 0.04) (Table 3). The most common site of vessel wall enhancement was ICA (n = 5; bilateral in 1 case and unilateral in 4 cases), followed by basilar artery (n = 4), MCA (n = 3), and ACA (n = 3). Seven cases showed stenosis on VWI. Enhancement pattern was smooth in 5 cases and nodular in 4 cases. No significant association between infarction and pattern of enhancement or stenosis on VWI was found (p > 0.05). TOF MRA showed abnormality in the form of stenosis in 7 cases, but failed to detect vascular involvement in two cases, in which VWI showed enhancement without significant stenosis.

Discussion

Bacterial CNS infections (Figs. 1 and 2)

Fig. 1.

Fig. 1

A case of bacterial meningitis in a 5-month-old male child with abscess in left Sylvian fissure showing central restriction of diffusion (thick arrows in a and b). Restricted diffusion is also seen in left MCA territory suggesting acute infarction (c). Coronal MIP TOF MRA image (d) showing nonvisualization of left ICA and MCA. Post-contrast axial and oblique coronal vessel wall imaging showing peripherally enhancing lesion in left Sylvian fissure (thick arrow in e and f) with nodular enhancement (inset in e) and severe stenosis of left M1 and M2 MCA (thin arrows in e and f)

Fig. 2.

Fig. 2

A 10-year-old female child, a known case of staphylococcal sepsis, presented with headache and fever. Axial DWI (a) shows restriction of diffusion along the ventral aspect of the brainstem (arrow), suggestive of subdural empyema. Sagittal FLAIR image (b) shows FLAIR hyperintense contents (arrow) along the clivus extending inferiorly up to the cervicomedullary junction. Post-contrast axial (c) and sagittal (d) vessel wall imaging shows smooth enhancement in the basilar artery (thick arrows in c and d, inset in c) and leptomeningitis along the cerebellar folia (thin arrows in c and d)

High morbidity and mortality is seen in bacterial infections of the CNS. These infections spread to the CNS from primary focus elsewhere in the body through contiguous or hematogenous spread. Contiguous spread may be seen secondary to sinusitis or post-traumatic skull base fracture or through iatrogenic inoculation of infections.

Pneumococcal meningitis commonly develops due to contiguous spread of infection from primary infections of PNS, temporal bone, or skull base fracture or hematogenous spread from primary lung infection. Comorbidities like DM, hypertension, and immunocompromised status increase the risk of CNS involvement. Streptococcal meningitis is more common than Staphylococcal meningitis [9]. Streptococcus pneumoniae has poorer prognosis than meningococcal infection because of the more invasive nature of S. pneumoniae [10]. Meningococcal, Haemophilus, and pneumococcal meningitis commonly affects children and young adults; however, due to vaccinations in the current era, incidence in children is reducing and adults are predominantly affected [11].

The pathophysiology of infective vasculitis in bacterial infections involves release of inflammatory cytokines which disrupt the blood–brain barrier and cause involvement of the vascular structures [12]. The adventitia of the subarachnoid vessels is formed by the arachnoid. So, it is believed that vascular involvement may be present since the early stage of the disease itself. The neutrophils infiltrate the intima with proliferation of intimal cells and endothelium. These cells accumulate below the intima and elevate it. Histopathological examinations have revealed that media remain unaffected and the adventitia was found to be contiguous with exudates [13]. In late stages, proliferative angiitis may develop which can cause partial arterial stenosis, while complete occlusion is rare. Necrotizing inflammation of the arterial wall may cause thrombosis, SAH, or mycotic aneurysm formation [14]. Mycotic aneurysms have very high rupture rate. The bacteria may also clog the small vessels in cases of florid bacteremia leading to infarcts.

Out of all the cases in our study population, infarction was seen in 5 cases (41.7%). Various studies have reported incidence of infarctions in bacterial infections ranging from 10 to 31% [13, 1517]. Smith and Landing studied 34 postmortem cases of H. influenzae meningitis and reported vascular involvement (arterial in 6 and venous in 10) in 16 of them [18]. Lyons and Leeds did cerebral angiography in a 6-month-old infant suffering from Haemophilus influenzae meningitis and found stenosis, occlusion, vasospasm, irregular dilatations, and slow arteriovenous transit [19]. Stroke rate is reported to be higher with Streptococcus pneumoniae (36%) than with Neisseria meningitidis (9%) [20]. Infarction in bacterial infections develops in the acute phase of the disease, unlike in tuberculosis where infarcts may develop in the chronic stage of the disease. We found maximum number of infarcts in the MCA territory (n = 5, 41.7%) and watershed territories (n = 3, 25%). Previous studies have shown that infarcts are multiple and typically formed at deep gray nuclei, gray–white junction, and thalami [4]. We also found such multiple focal infarcts in 3 cases.

Vessel wall enhancement was seen in a total of 5 cases (41.7%). There was no significant association between infarctions and vessel wall enhancement. Three cases showed stenosis on VWI and the findings corroborated on TOF MRA as well. In two cases, enhancement was present on VWI, but TOF MRA failed to detect vascular abnormality. In the study by Jan et al., TOF MRA was done in 5 of 13 cases of bacterial meningitis and vasculitic features were found in 3 of them [15].We also had one case of scrub typhus which is caused by Orientia tsutsugamushi. Bilateral thalamic T2 and FLAIR hyperintensity was seen; however, no vascular complication or vessel wall enhancement was seen. Scrub typhus is known to be associated with cerebrovascular complications, as it causes widespread endothelial injury [21].

Fungal CNS infections (Figs. 3 and 4)

Fig. 3.

Fig. 3

A 68-year-old male patient, a known case of fungal sinusitis, presented with altered sensorium and bilateral paraparesis. Post-contrast coronal 3D-T1-weighted image (a) showing enhancing contents in right ethmoid air cells with erosion of right fovea ethmoidalis (arrow in a) and leptomeningeal enhancement in bilateral frontal lobes (arrowhead in a). Acute infarcts are seen in bilateral ACA territories (b) with hemorrhagic transformation as seen in SWI image (c). Susceptibility changes are seen in lateral ventricles (arrow in c) suggestive of intraventricular hemorrhage. MIP oblique sagittal image of TOF MRA (d) showing fusiform mycotic aneurysm arising from right A2 ACA (arrowhead in d) with severe attenuation of distal right A2 ACA (thick arrow in d). Post-contrast coronal (e) and axial (f) vessel wall imaging showing enhancement along the walls of aneurysm (arrow in e) and nodular enhancement (inset in f) with moderate stenosis of right distal A2 ACA (arrow in f)

Fig. 4.

Fig. 4

A 42-year-old male patient, a known case of rhinocerebral mucormycosis, presented with altered sensorium. Axial (a) and sagittal (b) post-contrast vessel wall imaging shows heterogenous enhancement in the clivus (thin arrow in a and black arrow in b). Thick pachymeningeal enhancement was seen along the bilateral anterior temporal region (arrowheads in a). The basilar artery showed nodular enhancement pattern (thick white arrows in a and b, inset in b). Acute infarcts were seen in left hemipons (c) and right ACA-MCA watershed territory (d). The patient did not respond to the treatment and deteriorated. Repeat imaging done 1 month later revealed occlusion of the right ICA in distal petrous and cavernous segment (thick arrow in e) and basilar trunk (small thin arrow in e). New infarcts developed in bilateral cerebellum and right hemipons (f)

Vascular complications can be seen in fungal infections by both smaller yeasts as well as hyphae forming larger fungi. Yeast infections of the CNS (Cryptococcus, Candida, histoplasma, coccidioidomycosis etc.) occlude the smaller sized vessels leading to microabscesses, micro/focal infarcts, and microhemorrhages. These smaller sized fungi can easily travel to the microcirculation and invade the leptomeninges, leading to leptomeningitis.

Hyphae-forming fungi (e.g., Aspergillus, Mucor) on the other hand cause infarcts of variable sizes, ranging from punctate to lobar. Clinical course of the patients is generally indolent with recurrent and progressive ischemic symptoms. These larger fungi are angioinvasive and produce elastase, which destroys the elastin present in the arterial walls [22]. They affect medium- and large-sized vessels leading to thrombosis. The bland infarcts may also evolve into secondary abscesses. The infarcts are commonly seen in anterior circulation [23]. However, we found infarcts in all territories. Anterior circulation site predilection may be explained by the primary site of involvement, i.e., sinonasal fungal disease, from where fungus may invade anterior skull base and involve anterior parts of cerebral hemispheres. Intracranial spread from sinonasal infection is the most common mode of spread in India [24]. Cavernous sinus may get thrombosed with further involvement of cavernous ICA [3]. Such pattern of disease spread is seen in 10 to 20% of cases. We found anterior circulation involvement in 5 cases (41.7%). We also had 4 cases (33.3%) where basilar artery was involved secondary to extension of the pathology from sphenoid sinus to prepontine cistern. Apart from contiguous spread, hematogenous spread may also occur which causes angioinvasion by initial intimal necrosis in medium- and large-sized vessels. Perforating arteries are commonly involved with resultant infarction in the basal ganglia [1]. This predilection may be explained by invasion of vessel wall with involvement of origins of lenticulostriate and thalamoperforators. Fungal elements can also infiltrate the vessel wall with extension of hyphae in the lumen with subsequent embolization causing infarction [25].

In immunocompromised or diabetic individuals, mycotic aneurysms may be formed due to elastase-induced vessel wall destruction [26]. Infiltration and necrosis of vessel wall may cause SAH or ICH. The most common causative organism of mycotic ICA aneurysms is Aspergillus [27]. In one of our cases of sinonasal aspergillosis, there was formation of fusiform mycotic aneurysm in right A2 ACA which showed enhancement and had ruptured, leading to IVH (Fig. 3). Fungal mycotic aneurysms are generally fusiform in shape and proximal in location, as long segments of proximal larger vessels are involved, while bacterial mycotic aneurysms are round in shape and smaller in size and commonly involve distal vessels [1, 28, 29]. Cavernous and supraclinoid ICA are common sites of fungal mycotic aneurysms which are in close proximity to the affected sinuses [30, 31]. Fungal mycotic aneurysms have poor prognosis and carry high morbidity and mortality after rupture. These are managed by endovascular methods with concurrent antifungals. Unruptured mycotic aneurysms are primarily managed by antibiotics/antifungals and if they respond to medical treatment with reduction in size in follow-up imaging, then endovascular management is not required. However, increase in size or appearance of new aneurysms mandates interventional treatment [4].

Mucormycosis is a lethal opportunistic infection, seen in immunocompromised status, DM, etc. It causes necrotizing vasculitis with severe infiltration of intracranial structures, soft tissues of face, and adjacent neck spaces. Mucor has special predilection for internal elastic lamina of the arteries with fast hematogenous spread. The intracranial vessels show extensive damage to the endothelium, leading to its thrombosis. We also found vascular occlusion in 2 of 3 cases of Mucor infection. Posterior circulation involvement is seen in the advanced stage of the disease [32]. Watershed infarcts are seen when the artery is partially occluded [33]. We found such infarcts in 2 cases. In the current pandemic era of COVID-19, mucormycosis cases are on the rise which is likely related to treatment-induced immunosuppression, hyperglycemia, acidosis, or high ferritin levels [34, 35].

We also had two cases of Cryptococcus infection, one with gelatinous pseudocysts in the basal ganglia and the other with leptomeningitis. There was no vascular involvement on vessel wall imaging or infarction. Cryptococcus meningitis has been reported to cause infarcts in 26% of cases [36].

Smooth or nodular enhancement pattern is determined by histopathological basis of vascular involvement. Intramural granuloma formation or chronic proliferative angiitis may produce nodular pattern of enhancement, which has been described in tubercular meningitis [8, 37]. Nontubercular bacterial infection produces vascular involvement predominantly by contiguous extension of inflammation through adventitia [13]. So, it can be hypothesized that they may predominantly produce circumferential smooth enhancement in acute stages, while long-standing cases with development of proliferative angiitis may show nodular or eccentric enhancement. We also found 4 cases of bacterial infections with smooth enhancement and only 1 case with nodular enhancement. On the other hand, fungal infections produce granulomatous inflammation and thus can show nodular enhancement. However, we found smooth enhancement in 5 cases and nodular enhancement in 4 cases. Our results are only speculative and further studies are needed to correlate radiological findings of vessel wall enhancement with histopathological evidence and to prove these hypotheses.

Thus, vessel wall imaging can detect vascular involvement in bacterial and fungal infections and can help to identify territory at risk. By incorporating vessel wall imaging in routine imaging, we can improve our ability of disease prognostication in terms of detection of vascular complications. On identification of vascular involvement, early treatment can be initiated in the form of antiplatelets, corticosteroids, and anti-inflammatory drugs to preclude development of vascular complication, which can have great positive impact on patient management [3, 20]. Vessel wall imaging can perform better than TOF MRA for the detection of vascular involvement, as in both groups, TOF MRA failed to detect vascular involvement in 2 cases each, which were detected by VWI.

Other non-infective causes of vasculopathy in which vessel wall imaging plays an important diagnostic role include ICAD, primary CNS angiitis, RCVS, and Moyamoya disease [38]. ICAD can be differentiated from infective vasculitis on imaging by the presence of eccentric enhancing thickening which, on high-resolution T2WI, may also show presence of fibrofatty plaque [39]. Presence of positive remodeling is highly suggestive of ICAD as other stated etiologies cause stenosis of the involved arteries. Clinical profile and other distinctive parenchymal abnormalities in CNS infections are other pointers to differentiate the two. It is difficult to differentiate primary CNS angiitis from infective vasculitis in the absence of serological or CSF studies as both show circumferential enhancement on VWI [38]. Parenchymal imaging features are also similar in the form of infarcts, hemorrhages, and leptomeningeal enhancement. RCVS presents with thunderclap headache which resolves by 3 months, and is characterized by constriction of tunica media. The Moyamoya disease presents with recurrent strokes and is characterized histopathologically by fibrocellular intimal hyperplasia. Both RCVS and Moyamoya disease can be differentiated from infective vasculitis as both of them have characteristic clinical profile and show none to mild vascular enhancement on VWI [40, 41].

Limitation

Our study had few limitations. The sample size was small. Although all cases were proven CNS infections, we did not have any histopathological correlation of vascular findings. Cases were acquired in both 1.5-T and 3-T MRI scanners, which may have affected the results, as detection of vascular involvement is more accurate on 3 T. Also, it was difficult to assess distal vessels beyond second-order branches on VWI, which may have caused overlooking of some findings.

Conclusion

Cerebrovascular complications in CNS bacterial and fungal infections are poor prognostic markers. Vessel wall imaging can play a very significant role in identifying vascular involvement. VWI’s detection rate of vascular involvement is better than TOF MRA. Detection of vessel wall enhancement may prompt early treatment with antiplatelets, steroids, and anti-inflammatory drugs to prevent development of vascular complications. Thus, incorporation of vessel wall imaging in routine MRI should be considered for better management of these infections.

Abbreviations

ACA

Anterior cerebral artery

AICA

Anterior inferior cerebellar artery

BA

Basilar artery

CP

Cerebellopontine

COVID

Coronavirus disease

CSF

Cerebrospinal fluid

DSA

Digital subtraction angiography

FOV

Field of view

FS

Fat suppressed

GCS

Glasgow coma scale

ICA

Internal cerebral artery

ICAD

Intracranial atherosclerotic disease

MCA

Middle cerebral artery

MRA

Magnetic resonance angiography

PCA

Posterior cerebral artery

PCR

Polymerase chain reaction

PICA

Posterior inferior cerebellar artery

TOF

Time of flight

VA

Vertebral artery

VWI

Vessel wall imaging

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Chow F, Marra C, Cho T. Cerebrovascular disease in central nervous system infections. Semin Neurol. 2011;31(03):286–306. doi: 10.1055/s-0031-1287658. [DOI] [PubMed] [Google Scholar]
  • 2.Song JW, Shou H, Obusez EC, Raymond SB, Rafla SD, Kharal GA, et al. Spatial distribution of intracranial vessel wall enhancement in hypertension and primary angiitis of the CNS. Sci Rep 17. 2019;9(1):19270. doi: 10.1038/s41598-019-55634-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gerber O, Roque C, Coyle PK. Vasculitis owing to infection. Neurol Clin. 1997;15(4):903–925. doi: 10.1016/S0733-8619(05)70355-8. [DOI] [PubMed] [Google Scholar]
  • 4.Shen G, Shen X, Pu W, Zhang G, Lerner A, Gao B. Imaging of cerebrovascular complications of infection. Quant Imaging Med Surg. 2018;8(10):1039–1051. doi: 10.21037/qims.2018.11.08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Edjlali M, Qiao Y, Boulouis G, Menjot N, Saba L, Wasserman BA, et al. Vessel wall MR imaging for the detection of intracranial inflammatory vasculopathies. Cardiovasc Diagn Ther. 2020;10(4):1108–1119. doi: 10.21037/cdt-20-324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mandell DM, Mossa-Basha M, Qiao Y, Hess CP, Hui F, Matouk C, et al. Intracranial vessel wall MRI: principles and expert consensus recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2017;38(2):218–229. doi: 10.3174/ajnr.A4893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kern KC, Liebeskind DS. Vessel wall imaging of cerebrovascular disorders. Curr Treat Options Cardio Med. 2019;21(11):65. doi: 10.1007/s11936-019-0782-8. [DOI] [PubMed] [Google Scholar]
  • 8.Choudhary N, Vyas S, Modi M, Raj S, Kumar A, Sankhyan N, et al. MR vessel wall imaging in tubercular meningitis. Neuroradiology. 2021 doi: 10.1007/s00234-021-02678-y. [DOI] [PubMed] [Google Scholar]
  • 9.Fugate JE, Lyons JL, Thakur KT, Smith BR, Hedley-Whyte ET, Mateen FJ. Infectious causes of stroke. Lancet Infect Dis. 2014;14(9):869–880. doi: 10.1016/S1473-3099(14)70755-8. [DOI] [PubMed] [Google Scholar]
  • 10.van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 28. 2004;351(18):1849–59. doi: 10.1056/NEJMoa040845. [DOI] [PubMed] [Google Scholar]
  • 11.Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737–1746. doi: 10.1056/NEJMoa022823. [DOI] [PubMed] [Google Scholar]
  • 12.Täuber MG, Moser B. Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clin Infect Dis. 1999;28(1):1–11. doi: 10.1086/515079. [DOI] [PubMed] [Google Scholar]
  • 13.Friede RL. Cerebral infarcts complicating neonatal leptomeningitis: acute and residual lesions. Acta Neuropathol. 1973;23(3):245–253. doi: 10.1007/BF00687879. [DOI] [PubMed] [Google Scholar]
  • 14.Dodge PR, Swartz MN. Bacterial meningitis — a review of selected aspects special neurologic problems, postmeningitic complications and clinicopathological correlations. N Engl J Med 6. 1965;272(18):954–60. doi: 10.1056/NEJM196505062721806. [DOI] [PubMed] [Google Scholar]
  • 15.Jan W, Zimmerman RA, Bilaniuk LT, Hunter JV, Simon EM, Haselgrove J. Diffusion-weighted imaging in acute bacterial meningitis in infancy. Neuroradiology 1. 2003;45(9):634–9. doi: 10.1007/s00234-003-1035-8. [DOI] [PubMed] [Google Scholar]
  • 16.Gupta K, Banerjee A, Saggar K, Ahluwalia A, Saggar K. A prospective study of magnetic resonance imaging patterns of central nervous system infections in pediatric age group and young adults and their clinico-biochemical correlation. J Pediatr Neurosci. 2016;11(1):46. doi: 10.4103/1817-1745.181244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. N Engl J Med 5. 2006;354(1):44–53. doi: 10.1056/NEJMra052116. [DOI] [PubMed] [Google Scholar]
  • 18.Smith JF, Landing BH. Mechanisms of brain damage in H. influenzae meningitis. J Neuropathol Exp Neurol. 1960;19(2):248–65. doi: 10.1097/00005072-196004000-00006. [DOI] [PubMed] [Google Scholar]
  • 19.Lyons EL, Leeds NE. The angiographic demonstration of arterial vascular disease in purulent meningitis: report of a case. Radiology. 1967;88(5):935–938. doi: 10.1148/88.5.935. [DOI] [PubMed] [Google Scholar]
  • 20.Schut ES, Lucas MJ, Brouwer MC, Vergouwen MDI, van der Ende A, van de Beek D. Cerebral infarction in adults with bacterial meningitis. Neurocrit Care. 2012;16(3):421–427. doi: 10.1007/s12028-011-9634-4. [DOI] [PubMed] [Google Scholar]
  • 21.Lee J-W, Kim S-W, Chung J-H, Kim D-M, Yun N-R, Yoon SH. Scrub typhus and cerebrovascular injury: a phenomenon of delayed treatment? Am J Trop Med Hyg. 2013;89(1):119–122. doi: 10.4269/ajtmh.13-0094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hurst RW, Judkins A, Bolger W, Chu A, Loevner LA. Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation. AJNR Am J Neuroradiol. 2001;22(5):858–863. [PMC free article] [PubMed] [Google Scholar]
  • 23.George P, Ramiro JI, Gomes JA, Newey CR, Bhimraj A. Central nervous system fungal infection-related stroke: a descriptive study of mold and yeast-associated ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29(6):104759. doi: 10.1016/j.jstrokecerebrovasdis.2020.104759. [DOI] [PubMed] [Google Scholar]
  • 24.Murthy JM, Sundaram C, Prasad VS, Purohit AK, Rammurti S, Laxmi V. Aspergillosis of central nervous system: a study of 21 patients seen in a university hospital in south India. J Assoc Physicians India. 2000;48(7):677–681. [PubMed] [Google Scholar]
  • 25.Gabelmann A, Klein S, Kern W, Krüger S, Brambs H-J, Rieber-Brambs A, et al. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol. 2007;14(5):548–555. doi: 10.1111/j.1468-1331.2007.01755.x. [DOI] [PubMed] [Google Scholar]
  • 26.Muraoka S, Araki Y, Izumi T, Takeuchi K, Okamoto S, Wakabayashi T. Cerebral infarction and subarachnoid hemorrhage caused by central nervous system Aspergillus infection. World Neurosurg. 2016;90:705.e9–705.e13. doi: 10.1016/j.wneu.2016.03.021. [DOI] [PubMed] [Google Scholar]
  • 27.Horten BC, Abbott GF, Porro RS. Fungal aneurysms of intracranial vessels. Arch Neurol 1. 1976;33(8):577–9. doi: 10.1001/archneur.1976.00500080055008. [DOI] [PubMed] [Google Scholar]
  • 28.Lau AHC, Takeshita M, Ishii N. Mycotic (Aspergillus) arteritis resulting in fatal subarachnoid hemorrhage: a case report. Angiology. 1991;42(3):251–255. doi: 10.1177/000331979104200310. [DOI] [PubMed] [Google Scholar]
  • 29.Tang C, Patel NK, Miller R, Beale T, Hyare H. Spectrum of neurovascular complications from central nervous system infections (viral, bacterial and fungal) BJR Open. 2019;1(1):bjro.20180024. doi: 10.1259/bjro.20180024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hot A, Mazighi M, Lecuit M, Poiree S, Viard J-P, Loulergue P, et al. Fungal internal carotid artery aneurysms: successful embolization of an Aspergillus-associated case and review. Clin Infect Dis. 2007;45(12):e156–e161. doi: 10.1086/523005. [DOI] [PubMed] [Google Scholar]
  • 31.Razek AAKA, Castillo M. Imaging lesions of the cavernous sinus. AJNR Am J Neuroradiol. 2009;30(3):444–52. doi: 10.3174/ajnr.A1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Calli C, Savas R, Parildar M, Pekindil G, Alper H, Yunten N. Isolated pontine infarction due to rhinocerebral mucormycosis. Neuroradiology. 1999;41(3):179–181. doi: 10.1007/s002340050728. [DOI] [PubMed] [Google Scholar]
  • 33.Yousem DM, Galetta SL, Gusnard DA, Goldberg HI. MR findings in rhinocerebral mucormycosis. J Comput Assist Tomogr. 1989;13(5):878–882. doi: 10.1097/00004728-198909000-00023. [DOI] [PubMed] [Google Scholar]
  • 34.Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020 doi: 10.7759/cureus.10726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr S1871402121001570.10.1016/j.dsx.2021.05.019 [DOI] [PMC free article] [PubMed]
  • 36.Vela-Duarte D, Nyberg E, Sillau S, Pate A, Castellanos P, Chastain DB, et al. Lacunar stroke in cryptococcal meningitis: clinical and radiographic features. J Stroke Cerebrovasc Dis. 2019;28(6):1767–1772. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.043. [DOI] [PubMed] [Google Scholar]
  • 37.Chatterjee D, Radotra B, Vasishta R, Sharma K. Vascular complications of tuberculous meningitis: an autopsy study. Neurol India. 2015;63(6):926. doi: 10.4103/0028-3886.170086. [DOI] [PubMed] [Google Scholar]
  • 38.Lehman VT, Brinjikji W, Kallmes DF, Huston J, Lanzino G, Rabinstein AA, et al. Clinical interpretation of high-resolution vessel wall MRI of intracranial arterial diseases. BJR. 2016;89(1067):20160496. doi: 10.1259/bjr.20160496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Song JW, Wasserman BA. Vessel wall MR imaging of intracranial atherosclerosis. Cardiovasc Diagn Ther. 2020;10(4):982–993. doi: 10.21037/cdt-20-470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Obusez EC, Hui F, Hajj-Ali RA, Cerejo R, Calabrese LH, Hammad T, et al. High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. AJNR Am J Neuroradiol. 2014;35(8):1527–1532. doi: 10.3174/ajnr.A3909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Mossa-Basha M, de Havenon A, Becker KJ, Hallam DK, Levitt MR, Cohen WA, et al. Added value of vessel wall magnetic resonance imaging in the differentiation of moyamoya vasculopathies in a non-Asian cohort. Stroke. 2016;47(7):1782–1788. doi: 10.1161/STROKEAHA.116.013320. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neuroradiology are provided here courtesy of Nature Publishing Group

RESOURCES